Elysium Centre
At home treatment of depression and chronic pain
At A Glance
Depression affects 1 in 9 people across the world during their lifetime. Rates of depression and anxiety have risen rapidly during the COVID-19 pandemic, with 40% of US adults reporting symptoms and an average of 1 in 4 sufferings globally.
Elysium Centre addresses a trial-and-error approach to medication selection that hasn’t changed in decades. Nearly 70% of patients don’t find relief after their first treatment, 30% still won’t by their fourth
Our mission is to bring significant improvement to the treatment of depression, lifting the burden on patients, and the friends and loved ones who support them.
Our Company
Fast Growing Pharma Company
To broadly contribute to society through value creation based on innovative research and development activities for the betterment of healthcare and fuller lives of people worldwide
We respect the rights of all people associated with our company in conducting corporate activities. We do not discriminate or harass anyone.

Olivia Michelle
Founder, CEO of evermed

Therapeutic Areas of Focus
Neurology and Oncology
Many essential cytostatic agents often cause vomiting and nausea. For this reason, most patients are usually given medication to avoid or prevent such serious side effects before undergoing emetogenic chemotherapy.
Narcolepsy patients often suffer from intense hallucinations while falling asleep or waking up. These can include seeing, hearing or touching things that don’t exist in reality but are often experienced as highly realistic. The hallucinations are mainly perceived as threatening or unpleasant.
In healthy people sleep paralysis, which is the total inability to move, is normal during sleep and prevents them moving around while dreaming. Patients with narcolepsy, in contrast, often suffer from sleep paralysis at the beginning or end of sleep and they may consciously experience being paralyzed. This could last from a few seconds to some minutes and can be a very frightening experience